Analystreport

Milestone Pharmaceuticals (MIST) was downgraded by Zacks Research from "strong-buy" to "hold".

Milestone Pharmaceuticals Inc. - Common Shares  (MIST) 
Last milestone pharmaceuticals inc. - common shares earnings: 3/6 07:00 am Check Earnings Report